Login

Financial Snapshot

Revenue
TTM
$3.771B
Gross Margin
TTM
58.3%
Net Income
TTM
$449.2M
Current Assets
2026 Q2
$3.717B
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
163.53%
Total Assets
2026 Q2
$24.53B
Total Liabilities
2026 Q2
$9.239B
Book Value
2026 Q2
15.29B
Cash
2026 Q2
$462.0M
P/E
TTM
83.83
Free Cash Flow
TTM
$264.0M

Stock Price

Loading...
Market Cap: $37.661 Billion

About Waters Corp

Waters Corporation (NYSE: WAT) is an analytical instruments company that designs, manufactures, sells, and services high-performance liquid chromatography, ultra-performance liquid chromatography, and mass spectrometry technology systems. Revenue comes from instrument system sales, chromatography columns, other consumable products, and post-warranty service plans. Waters has operated in chromatography and mass spectrometry for more than 65 years, serving pharmaceutical, clinical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers across life sciences, materials sciences, and food sciences. Its LC and MS products are frequently sold as integrated LC-MS systems running on common software platforms, creating switching costs tied to installed-base consumables and service contracts. The consumables and service revenue streams provide recurring income layered on top of capital instrument sales.

Revenue model
Transactional instrument sales combined with recurring revenue from chromatography columns, other consumables, and post-warranty service plans. Customers require ongoing consumable replenishment and service support after initial instrument purchase, generating aftermarket revenue tied to the installed base.
Products and services
High-performance liquid chromatography (HPLC) systems, ultra-performance liquid chromatography (UPLC) systems, mass spectrometry (MS) systems, integrated LC-MS instrument systems, chromatography columns, consumable products, software platforms, and post-warranty service plans. The company also has a thermal analysis business serving materials sciences.
Customers and end markets
Pharmaceutical companies, clinical laboratories, biochemical researchers, industrial manufacturers, nutritional safety testers, environmental labs, academic institutions, and governmental agencies. Primary applications include drug discovery and development, quality assurance, research and development, and laboratory analysis of chemical, physical, and biological composition of materials.
Value-chain role
Instrument manufacturer and aftermarket consumables and service provider. Waters sits upstream of pharmaceutical, industrial, and research workflows, supplying the analytical tools and ongoing supplies required for laboratory testing and quality control.

Source: SEC 10-K, filed 2026-02-23

Industry: Laboratory Analytical Instruments Peers: Agilent Technologies Inc Avantor Inc Bio Rad Laboratories Inc Bio-Techne Corp Revvity Inc Illumina Inc IQVIA Holdings Inc Mettler-toledo International Inc Thermo Fisher Scientific Inc West Pharmaceutical Services Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support